JO
AUGX

John Overdeck’s Augmedix, Inc. Common Stock AUGX Stock Holding History

John Overdeck’s Portfolio AUGX Stock Details AUGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-31,751
Closed -$27.9K – 3405
2024
Q2 		$27.9K Sell
31,751
-101,979
-76% -$210K ﹤0.01% 2922
2024
Q1 		$547K Sell
133,730
-122,227
-48% -$547K ﹤0.01% 2292
2023
Q4 		$1.5M Buy
+255,957
New +$1.35M ﹤0.01% 1818
2023
Q3 		– Sell
-12,139
Closed -$58.4K – 3300
2023
Q2 		$58.4K Buy
+12,139
New +$42K ﹤0.01% 2809

Other funds holding AUGX

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $111M AUM 205.39% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.16B AUM 43.32% 1-Year Est. Return
SM
Samjo Management New York $293M AUM 57.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return
TC
Trium Capital London, United Kingdom $163M AUM 45.8% 1-Year Est. Return
GCIA
Gabelli & Co Investment Advisers Rye, New York $688M AUM 63.39% 1-Year Est. Return
HIM
HGC Investment Management Toronto, Ontario, Canada $507M AUM 6.15% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

John Overdeck's AUGX Position: Q3 2024 in Review

John Overdeck sold out of Augmedix, Inc. Common Stock (AUGX) in Q3 2024, closing a stake of 31,751 shares — an estimated $27.9K sold.

John Overdeck first reported a position in AUGX in Q2 2023 and held it in 4 quarters. The position peaked at $1.5M in Q4 2023. 45 funds tracked by Wall St. Rank hold AUGX as of Q3 2024.

  • John Overdeck reported no remaining Augmedix, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • John Overdeck sold 31,751 Augmedix, Inc. Common Stock shares in Q3 2024, an estimated $27.9K.
  • John Overdeck first reported a position in Augmedix, Inc. Common Stock in Q2 2023 and held it in 4 quarters.
  • John Overdeck's Augmedix, Inc. Common Stock position peaked at $1.5M in Q4 2023.
  • 45 funds tracked by Wall St. Rank held Augmedix, Inc. Common Stock as of Q3 2024.

Based on Two Sigma Investments's 13F filing for Q3 2024, filed 14 Nov 2024.